Ronald A. Martell's Insider Trades & SAST Disclosures
Ronald A. Martell's most recent trade in Jasper Therapeutics Inc was a trade of 130,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 13, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Ronald A. Martell.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Jasper Therapeutics Inc | Ronald A. Martell | Director, President, CEO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 130,000 | 130,000 | - | - | Stock Option (right to buy) | |
| Jasper Therapeutics Inc | Ronald A. Martell | Director, President, CEO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 20,000 | 20,000 | - | - | Performance Restricted Stock Units | |
| Jasper Therapeutics Inc | Ronald A. Martell | Director, President, CEO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Jasper Therapeutics Inc | Ronald Martell A. | Director, President, CEO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Jasper Therapeutics Inc | Ronald A. Martell | Director, President, CEO and Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.46 per share. | 12 Apr 2023 | 87,531 | 418,719 | - | 1.5 | 127,795 | Voting Common Stock |
| Jasper Therapeutics Inc | Ronald A. Martell | Director, President, CEO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 500,000 | 500,000 | - | - | Stock Option (right to buy) | |
| Jasper Therapeutics Inc | Ronald A. Martell | Director, President, CEO & Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 1,093,831 | 1,093,831 | - | - | Stock Option (right to buy) | |
| Jasper Therapeutics Inc | Ronald A. Martell | Director, President, CEO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2022 | 506,250 | 506,250 | - | 0 | Voting Common Stock | |
| Jasper Therapeutics Inc | Ronald A. Martell | Director, President, CEO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2022 | 1,704,328 | 1,704,328 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges